We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
-3.48%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$85.2B
AUM Growth
+$4.83B
Cap. Flow
+$8.98B
Cap. Flow %
10.54%
Top 10 Hldgs %
12.02%
Holding
4,686
New
822
Increased
1,556
Reduced
1,625
Closed
650

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$786M
2
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$409M
3
MU icon
Micron Technology
MU
+$379M
4
T icon
AT&T
T
+$372M
5
MDT icon
Medtronic
MDT
+$370M

Sector Composition

Rank Sector Weight
1 Healthcare 18.69%
2 Technology 14.95%
3 Consumer Discretionary 11.34%
4 Consumer Staples 10.7%
5 Communication Services 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARTL icon
3826
Artelo Biosciences
ARTL
$2.68M
$82K ﹤0.01%
676
+273
+68% +$31.4K
RGF
3827
DELISTED
The Real Good Food Company, Inc. Class A Common Stock
RGF
$82K ﹤0.01%
+868
New +$68.4K
MOHO
3828
DELISTED
ECMOHO Limited American Depositary Shares
MOHO
$82K ﹤0.01%
293,407
+60,000
+26% +$17.9K
IMNM icon
3829
Immunome
IMNM
$2.58B
$80K ﹤0.01%
+14,000
New +$105K
OTRK
3830
DELISTED
Ontrak
OTRK
$79K ﹤0.01%
+386
New +$105K
TOMZ icon
3831
TOMI Environmental Solutions
TOMZ
$12.3M
$78K ﹤0.01%
28,667
+11,300
+65% +$36.6K
SCPS
3832
DELISTED
Scopus BioPharma Inc. Common Stock
SCPS
$78K ﹤0.01%
112,523
+91,623
+438% +$88.4K
BMEA icon
3833
Biomea Fusion
BMEA
$84.6M
$77K ﹤0.01%
17,300
+200
+1% +$1.3K
DUO
3834
Fangdd Network Group
DUO
$22.1M
$77K ﹤0.01%
58
-61
-51% -$81K
JG
3835
Aurora Mobile
JG
$33.4M
$77K ﹤0.01%
3,520
+2
+0.1% +$41
LTRN icon
3836
Lantern Pharma
LTRN
$33.6M
$77K ﹤0.01%
+10,700
New +$71.5K
TCON
3837
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$77K ﹤0.01%
1,460
-9,090
-86% -$457K
HTGM
3838
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$77K ﹤0.01%
4,626
+75
+2% +$2.41K
NEW
3839
DELISTED
Puxin Limited American Depositary Shares, each representing twenty Ordinary Shares
NEW
$77K ﹤0.01%
37,140
+9,820
+36% +$22.6K
ECOR icon
3840
electroCore
ECOR
$54.9M
$76K ﹤0.01%
8,675
-7,181
-45% -$65.1K
QXO
3841
QXO Inc
QXO
$13.8B
$76K ﹤0.01%
+2,903
New +$83.7K
EXTN
3842
DELISTED
Exterran Corporation
EXTN
$76K ﹤0.01%
+12,200
New +$65K
DERM icon
3843
Journey Medical
DERM
$175M
$75K ﹤0.01%
+15,600
New +$77.9K
AIXC
3844
AIxCrypto Holdings Inc
AIXC
$13.4M
$75K ﹤0.01%
+228
New +$89K
ML
3845
DELISTED
MoneyLion Inc.
ML
$74K ﹤0.01%
+987
New +$77K
ELDN icon
3846
Eledon Pharmaceuticals
ELDN
$261M
$73K ﹤0.01%
18,473
+4,800
+35% +$18.6K
AAU
3847
DELISTED
Almaden Minerals Ltd
AAU
$73K ﹤0.01%
203,700
-269,102
-57% -$86.6K
PYPD icon
3848
PolyPid
PYPD
$82.3M
$72K ﹤0.01%
+440
New +$66.7K
TIRX
3849
DELISTED
Tian Ruixiang Holdings
TIRX
$72K ﹤0.01%
556
+172
+45% +$26.6K
CNTB
3850
Connect Biopharma Holdings
CNTB
$127M
$71K ﹤0.01%
23,500
+12,700
+118% +$53.6K

Similar funds

Renaissance Technologies's Q1 2022 Portfolio in Review

As of Q1 2022, Renaissance Technologies held 4,686 positions worth $85.2B, up 6% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Renaissance Technologies deployed $8.98B of net new capital in Q1 2022, opening 822 new positions and adding to 1,556 existing holdings. Its largest new stake was Advanced Micro Devices: 7,107,290 shares worth $777M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $409M trimmed.

  • Renaissance Technologies's largest Q1 2022 buy was Advanced Micro Devices: 7,107,290 shares worth $777M.
  • Renaissance Technologies added most to Tesla in Q1 2022, an estimated $759M increase.
  • Renaissance Technologies's biggest Q1 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $409M.
  • Renaissance Technologies fully exited Microsoft in Q1 2022, selling an estimated $786M.
  • Renaissance Technologies's ten largest holdings make up 12% of its $85.2B portfolio in Q1 2022.
  • Renaissance Technologies opened 822 new positions and closed 650 in Q1 2022.
  • Renaissance Technologies's portfolio value rose 6% quarter-over-quarter to $85.2B.

Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.